Testing effectiveness (Phase 2)Study completedNCT01110707
What this trial is testing
A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
Who this might be right for
InfertilityOvulation Induction
Merck KGaA, Darmstadt, Germany 131